Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seeds | 3 | 2025 | 46 | 0.480 |
Why?
|
| Plant Extracts | 3 | 2025 | 302 | 0.390 |
Why?
|
| Euphorbia | 2 | 2022 | 2 | 0.380 |
Why?
|
| Colonic Neoplasms | 2 | 2022 | 223 | 0.310 |
Why?
|
| Colorectal Neoplasms | 2 | 2025 | 512 | 0.290 |
Why?
|
| Mouth Neoplasms | 3 | 2013 | 60 | 0.280 |
Why?
|
| Antioxidants | 3 | 2025 | 443 | 0.250 |
Why?
|
| Brassicaceae | 1 | 2025 | 3 | 0.230 |
Why?
|
| Anticarcinogenic Agents | 1 | 2025 | 77 | 0.220 |
Why?
|
| Plant Leaves | 1 | 2024 | 136 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2025 | 213 | 0.200 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2024 | 134 | 0.190 |
Why?
|
| Carbonic Anhydrases | 1 | 2022 | 8 | 0.190 |
Why?
|
| Ocimum basilicum | 1 | 2022 | 5 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 40 | 0.180 |
Why?
|
| Biological Products | 1 | 2022 | 91 | 0.170 |
Why?
|
| Gene Flow | 1 | 2019 | 31 | 0.150 |
Why?
|
| Genome, Human | 1 | 2019 | 144 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2022 | 460 | 0.130 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2013 | 6 | 0.100 |
Why?
|
| Receptors, Endothelin | 1 | 2013 | 7 | 0.100 |
Why?
|
| Saliva | 2 | 2013 | 119 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 238 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 146 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 526 | 0.090 |
Why?
|
| Registries | 1 | 2013 | 437 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 223 | 0.090 |
Why?
|
| Receptor, Endothelin B | 1 | 2010 | 4 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2013 | 403 | 0.080 |
Why?
|
| Diagnosis | 1 | 2010 | 10 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2010 | 21 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 83 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 186 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2025 | 1455 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 2676 | 0.070 |
Why?
|
| Humans | 11 | 2025 | 43102 | 0.060 |
Why?
|
| Cucurbitaceae | 1 | 2024 | 6 | 0.060 |
Why?
|
| HT29 Cells | 1 | 2024 | 60 | 0.060 |
Why?
|
| Piracetam | 1 | 2004 | 1 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2004 | 40 | 0.050 |
Why?
|
| Calcium Phosphates | 1 | 2022 | 15 | 0.050 |
Why?
|
| alpha-Linolenic Acid | 1 | 2022 | 1 | 0.050 |
Why?
|
| Linoleic Acid | 1 | 2022 | 9 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2022 | 14 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2022 | 35 | 0.050 |
Why?
|
| Plant Oils | 1 | 2022 | 20 | 0.050 |
Why?
|
| Mice | 2 | 2025 | 6644 | 0.050 |
Why?
|
| Biotransformation | 1 | 2022 | 69 | 0.050 |
Why?
|
| Azoxymethane | 1 | 2022 | 9 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2022 | 19 | 0.050 |
Why?
|
| Niacin | 1 | 2002 | 23 | 0.050 |
Why?
|
| Coumarins | 1 | 2022 | 45 | 0.050 |
Why?
|
| Neoplasms | 1 | 2013 | 1377 | 0.050 |
Why?
|
| Biological Availability | 1 | 2022 | 116 | 0.050 |
Why?
|
| Animals | 3 | 2025 | 16992 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 134 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2022 | 232 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 1869 | 0.040 |
Why?
|
| Ethanol | 1 | 2022 | 224 | 0.040 |
Why?
|
| Africa, Northern | 1 | 2019 | 6 | 0.040 |
Why?
|
| Portugal | 1 | 2019 | 10 | 0.040 |
Why?
|
| History, Ancient | 1 | 2019 | 13 | 0.040 |
Why?
|
| Chromosomes, Human, Y | 1 | 2019 | 15 | 0.040 |
Why?
|
| Spain | 1 | 2019 | 44 | 0.040 |
Why?
|
| Agriculture | 1 | 2019 | 66 | 0.040 |
Why?
|
| Apoptosis | 1 | 2024 | 1568 | 0.030 |
Why?
|
| Male | 5 | 2025 | 23409 | 0.030 |
Why?
|
| Genomics | 1 | 2019 | 293 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 968 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3735 | 0.030 |
Why?
|
| Palatal Neoplasms | 1 | 2013 | 2 | 0.030 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 2 | 0.030 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 9 | 0.030 |
Why?
|
| Alphapapillomavirus | 1 | 2013 | 31 | 0.030 |
Why?
|
| SEER Program | 1 | 2013 | 164 | 0.020 |
Why?
|
| Middle Aged | 4 | 2013 | 12222 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1078 | 0.020 |
Why?
|
| Mental Processes | 1 | 2010 | 16 | 0.020 |
Why?
|
| Problem Solving | 1 | 2010 | 38 | 0.020 |
Why?
|
| Mouth | 1 | 2010 | 54 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 8214 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2013 | 1413 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2013 | 376 | 0.020 |
Why?
|
| Physicians | 1 | 2010 | 188 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 734 | 0.020 |
Why?
|
| Adult | 2 | 2013 | 13872 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 2853 | 0.010 |
Why?
|
| United States | 1 | 2013 | 5205 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 3994 | 0.010 |
Why?
|
| Female | 2 | 2013 | 24698 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 5080 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 6081 | 0.010 |
Why?
|